Marex Group (MRX) exec gets 33,582-share award, now holds 1,498,834
Rhea-AI Filing Summary
Marex Group Ltd (MRX) reported that President Simon Van Den Born acquired 33,582 Ordinary Shares on August 19, 2026 through the vesting of a prior equity award, at a reported price of $0.00 per share, bringing his directly held and award-related position to 1,498,834 Ordinary Shares.
The shares relate to a September 6, 2023 grant under the 2022 Annual Long Term Incentive Plan, for which the Remuneration Committee determined on August 19, 2026 that performance conditions based on return on equity and growth in adjusted operating profit before tax had been met; the award remains subject to time-based vesting and is scheduled to fully vest on September 6, 2026. The reported holdings include 272,659 shares underlying deferred bonus plan awards, each representing a contingent right to receive one Marex ordinary share upon vesting and settlement.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 33,582 shares
Net Buy
1 txn
Insider
Van Den Born Simon
Role
President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares F1, F2 | 33,582 | $0.00 | $0.00 |
Holdings After Transaction:
Ordinary Shares — 1,498,834 shares (Direct)
Footnotes (2)
- F1. On September 6, 2023, the Reporting Person was granted an award under the Issuer's 2022 Annual Long Term Incentive Plan (the "Plan"), which vests in the form of ordinary shares subject to (i) performance conditions, including a minimum return on equity underpin and growth in adjusted operating profit before tax, and (ii) continued service through the third anniversary of the grant date, in each case subject to the terms of the Plan. On August 19, 2026, the Remuneration Committee of the Issuer's Board of Directors determined that the performance conditions had been met. The award remains subject to time-based vesting and will fully vest on September 6, 2026.
- F2. The number of ordinary shares reported herein includes (i) 33,582 shares vesting under the Issuer's 2022 Annual Long Term Incentive Plan as described in footnote 1, and (ii) 272,659 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Key Figures
Ordinary Shares acquired: 33,582 shares
Transaction price per share: $0.00 per share
Total shares following transaction: 1,498,834 shares
+2 more
5 metrics
Ordinary Shares acquired
33,582 shares
Grant/award acquisition on August 19, 2026 under the 2022 Annual Long Term Incentive Plan
Transaction price per share
$0.00 per share
Reported for the 33,582 Ordinary Shares acquired via award vesting
Total shares following transaction
1,498,834 shares
Direct holdings and award-related interests after the August 19, 2026 transaction
Deferred bonus plan awards underlying shares
272,659 shares
Number of Marex ordinary shares underlying deferred bonus plan awards held by the reporting person
LTIP shares vesting
33,582 shares
Shares vesting under the Issuer's 2022 Annual Long Term Incentive Plan
Key Terms
2022 Annual Long Term Incentive Plan, return on equity, adjusted operating profit before tax, deferred bonus plan awards, +1 more
5 terms
2022 Annual Long Term Incentive Plan financial
"granted an award under the Issuer's 2022 Annual Long Term Incentive Plan (the "Plan")"
return on equity financial
"subject to (i) performance conditions, including a minimum return on equity underpin"
Return on equity shows how effectively a company uses its shareholders' money to generate profit. It is calculated by dividing the company's net profit by its shareholders' equity, indicating how much profit is earned for each dollar invested by owners. Higher return on equity suggests the company is good at turning investments into earnings, which can be an important factor for investors assessing its profitability and efficiency.
adjusted operating profit before tax financial
"and growth in adjusted operating profit before tax"
deferred bonus plan awards financial
"shares underlying deferred bonus plan awards previously granted to the Reporting Person"
Deferred bonus plan awards are payments promised to employees or executives that are earned now but paid out later, often only if certain performance goals are met or the employee remains with the company. For investors, they matter because they influence management’s incentives and company expenses over time—like a delayed paycheck that encourages someone to stay and meet targets—and can affect future cash needs, reported compensation costs, and potential share dilution.
contingent right to receive financial
"Each award represents a contingent right to receive one (1) ordinary share"
FAQ
What transaction did Marex Group Ltd (MRX) report for President Simon Van Den Born?
Marex Group Ltd reported that President Simon Van Den Born acquired 33,582 Ordinary Shares on August 19, 2026 via a grant/award under the company’s equity incentive arrangements, at a reported price of $0.00 per share, increasing his reported holdings to 1,498,834 shares.
What are the key terms of the 2022 Annual Long Term Incentive Plan award reported for MRX?
The award under Marex’s 2022 Annual Long Term Incentive Plan was granted on September 6, 2023 and vests in ordinary shares subject to (i) performance conditions, including a minimum return on equity underpin and growth in adjusted operating profit before tax, and (ii) continued service through the third anniversary.
When did Marex Group Ltd determine that the performance conditions for the MRX LTIP award were met?
On August 19, 2026, the Remuneration Committee of Marex Group Ltd’s Board of Directors determined that the performance conditions for the 2022 Annual Long Term Incentive Plan award had been met. The award remains subject to time-based vesting and is scheduled to fully vest on September 6, 2026.
What portion of Simon Van Den Born’s MRX holdings relate to deferred bonus plan awards?
Of Simon Van Den Born’s reported 1,498,834 Ordinary Shares, the total includes 272,659 shares underlying deferred bonus plan awards previously granted. Each deferred bonus award represents a contingent right to receive one Marex ordinary share upon vesting and settlement.
Was the Marex Group Ltd (MRX) Form 4 transaction executed under a Rule 10b5-1 trading plan?
The Form 4 indicates the Rule 10b5-1 checkbox as not checked (aff_10b5_one = false), and the footnotes describe vesting of incentive awards rather than open-market trades. The filing does not describe this award vesting as executed under a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
